❋

Strategic Diligence and Capital Readiness for a Platform-Based Oncology Company

About Client

The client is an early-stage oncology platform company preparing for external capital raise and strategic partnering discussions. The company had strong scientific assets but required clearer positioning around intellectual property strength, partnership strategy, and downstream commercial potential.

Study 1: A strategic diligence and positioning engagement supporting capital raise

Study 2: Partnering readiness assessment

Challenge

  • Investor and partner questions around IP defensibility and freedom to operate

  • Limited clarity on optimal pharma/biotech partnering pathways

  • Need for finance-ready deal structures aligned to preclinical maturity

Solution

  • Conducted a patent landscape and freedom-to-operate analysis to assess IP robustness

  • Mapped potential global pharma and biotech partners aligned to the platform’s modality and mechanism

  • Worked with senior business development leadership to design licensing, co-development, and milestone-based deal structures grounded in development risk and timelines

Results

The engagement strengthened external confidence and improved execution readiness across fundraising and partnering

  • Strengthened investor confidence through a clear, evidence-based value narrative

  • Enabled targeted outreach to high-fit strategic partners

  • Equipped management with concrete deal frameworks to support fundraising and partnering discussions